Attune
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
250 W 55th St Fl 34, New York, New York,...Phone Number
(646) 597-6987Website
www.attunepharmaceutical.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Attune
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Attune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Attune is spiking on competitors!
Attune, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Attune recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Attune
Product Launch: Get notified when Attune launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Attune has new funding data
Check if Attune has recently received funding, and reach out quickly before it becomes old news!
Click to see if Attune had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Attune
Find 2 more new buyers
Attune financials insights
Gather financial insights about Attune, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$23M
Attune Tech Stack
A closer look at the technologies used by Attune
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Attune
Attune Pharmaceuticals is dedicated to pioneering novel treatments for rare diseases through the development of innovative, orally-administered small-molecule therapeutics. The company focuses on targeting serine proteases to enhance patient outcomes and improve quality of life. Their lead drug candidate, ATN-249, has shown promising results in pre... Read More
